Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics.

Antimicrobial Agents and Chemotherapy
H Yamaguchi, K Iwata

Abstract

The specific affinity for membrane lipids and the membrane selectivity of three imidazole derivatives, clotrimazole, miconazole, and econazole, were studied using various types of liposomes with respect to the lecithin fatty acyl group composition and the liposome content and composition of sterol as membrane models. The sensitivity of liposomes to these drugs was primarily dependent upon the lecithin fatty acyl group composition. With sterol-free liposome systems, each imidazole induced maximum release of trapped glucose as a marker from the unsaturated dioleoyl lecithin liposomes, minimum release from the saturated dipalmitoyl lecithin liposomes, and intermediate release from egg lecithin liposomes. The sensitivity of the dipalmitoyl lecithin liposomes to any imidazole drug was not influenced by the incorporation of cholesterol or ergosterol. On the other hand, clotrimazole-induced permeability changes of liposomes prepared from unsaturated dioleoyl lecithin or egg lecithin were greatly enhanced by the incorporation of ergosterol, whereas they were suppressed by cholesterol incorporation. The sensitivity of liposomes prepared from these unsaturated lecithins to miconazole and econazole was also augmented by ergosterol incorpo...Continue Reading

References

Jan 14, 1975·Biochimica Et Biophysica Acta·M ImaiS Nojima
Jan 1, 1976·Journal of Cutaneous Pathology·R J Holt
Jan 17, 1972·Biochimica Et Biophysica Acta·W PacheR Hillaby
May 22, 1973·Biochemistry·C C HsuChen, D S Feingold
Apr 16, 1973·Biochemical and Biophysical Research Communications·C C HsuChen, D S Feingold
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·C C Hsuchen, D S Feingold
Jan 10, 1968·Biochimica Et Biophysica Acta·S C KinskyL L van Deenen

❮ Previous
Next ❯

Citations

Jan 1, 1983·General Pharmacology·S OgaW J Yasaka
Oct 20, 2005·Journal of Bioscience and Bioengineering·T AsanoS Kawakita
Feb 1, 1988·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·R D Cannon, D Kerridge
Oct 31, 2008·The Journal of Antimicrobial Chemotherapy·Ruan EllsCarolina H Pohl
Nov 1, 1979·Antimicrobial Agents and Chemotherapy·I J SudD S Feingold
Jul 1, 1981·Antimicrobial Agents and Chemotherapy·I J Sud, D S Feingold
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·I J Sud, D S Feingold
Feb 25, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gert WörleHeike Bunjes
Oct 1, 1982·Biochemical Pharmacology·R ArndtJ Schulz-Harder
Aug 15, 1982·Biochemical Pharmacology·H Van den BosscheJ Van Cutsem
Jun 1, 1981·The Journal of Investigative Dermatology·I J Sud, D S Feingold

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.